PMC:7696151 / 112072-112602
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 4073 | 98-106 | Species | denotes | patients | Tax:9606 |
| 4074 | 194-202 | Species | denotes | patients | Tax:9606 |
| 4075 | 356-364 | Species | denotes | patients | Tax:9606 |
| 4076 | 380-388 | Species | denotes | patients | Tax:9606 |
| 4077 | 419-427 | Species | denotes | patients | Tax:9606 |
| 4078 | 505-513 | Species | denotes | patients | Tax:9606 |
| 4196 | 89-97 | Disease | denotes | infected | MESH:D007239 |
| 4197 | 208-217 | Disease | denotes | pneumonia | MESH:D011014 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T266 | 208-217 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T759 | 0-530 | Sentence | denotes | Gautret, et al. (2020) [33] Uncontrolled, non-comparative, observational study80 mildly infected patients 600 mg/day HCQ per 10 days + 500 mg AZM on day 1 followed by 250 mg/day for 4 daysFor patients with pneumonia and NEWS score ≥ 5 ceftriaxone was added to HCQ/AZM treatment On day 7, nasopharyngeal viral load tested by qPCR was negative for 83% of patients and for 93% of patients at day 8.At day 5 in 97.5% of patients, virus cultures of the respiratory sample were negative.After 10 days only 2 patients were contagious. |